Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
about
Targeted approaches to induce immune tolerance for Pompe disease therapyMitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.Production of Retrovirus-Based Vectors in Mildly Acidic pH Conditions.Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses.Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE.
P2860
Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
@en
type
label
Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
@en
prefLabel
Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
@en
P2860
P356
P1433
P1476
Lentiviral hematopoietic stem cell gene therapy in inherited metabolic disorders.
@en
P2093
Gerard Wagemaker
P2860
P304
P356
10.1089/HUM.2014.102
P577
2014-09-17T00:00:00Z